The Interventional Oncology Center

Filter Your Results




Merit Medical Receives FDA Clearance for EmboCube Embolization Gelatin

November 29, 2018 -- Merit Medical Systems, Inc. announced that it has received FDA 510(k) clearance for EmboCube embolization gelatin. EmboCube is indicated for use in emboli…

Boston Scientific Announces Agreement on Terms to Acquire BTG plc

November 20, 2018 -- Boston Scientific Corporation has reached an agreement on terms of a recommended offer to acquire BTG plc. According to a company announcement, the boards…

Applying Evidence in Interventional Oncology

Nadine Abi-Jaoudeh, MD; and Julius Chapiro, MD

October 2018— Interventional oncology is a rapidly growing field within interventional radiology that aspires to become one of the pillars of

Tumor Boards in Interventional Oncology

With Ghassan K. Abou-Alfa, MD; Justin D. Blasberg, MD; Frank C. Detterbeck, MD, FACS, FCCP; Dimitris Filippiadis, MD, PhD, EBIR; Ryan Hickey, MD; Howard S. Hochster, MD; Zeljka Jutric, MD; Alexis Kelekis, MD, PhD, EBIR, FSIR; Maureen P. Kohi, MD, FSIR; Alexander Lam, MD; Robert J. Lewandowski, MD, FSIR; Areo Saffarzadeh, MD, MS; Mansi R. Shah, MD; Ronald F. Wolf, MD; Emi J. Yoshida, MD; and Etay Ziv, MD, PhD

October 2018—A multidisciplinary discussion of the approach to treatment for four patients with cancers of varying origins and severities.

Commentary: Staying on Course

Nadine Abi-Jaoudeh, MD

October 2018—Obtaining the highest level of evidence in interventional oncology requires that we stay on course and strive for positive prospective randomized trials.

Weighing Evidence Quality in Interventional Oncology

Derek Biederman, MD; and Edward Kim, MD

October 2018—The importance of understanding the levels of evidence related to IO therapies and areas for future research.

Arterial Oncologic Interventions for Liver-Dominant Metastases

W. Brad Butler, BS; and Daniel B. Brown, MD

October 2018—The current state of evidence for arterial interventions for liver metastases.

Nonsurgical Local Therapies for Lung Metastases and Non–Small Cell Lung Cancer

Thierry de Baere, MD

October 2018—Clinical data examining the use of available treatment options for selected lung cancer cases.



2017 Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.